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Identification of IgE
Kimishige Ishizaka, MD, PhD, and Teruko Ishizaka, MD, PhD La Jolla, CalifAbbreviations used
PK: Prausnitz-K€ustner
WHO: World Health OrganizationProgress in protein chemistry in the 1950s revealed that the
biologic activities of proteins, such as hemoglobin and enzymes,
are based on partial structures in the protein molecules. This
principle suggested to us the possibility that the human
antibodies responsible for induction of reaginic hypersensitivity
reactions might have unique structures that are lacking in the
antibody molecules involved in immunity and that the
differences in the structures of human antibody molecules can
be recognized by the immune systems of experimental animals.
Our studies were based on the hypothesis that reaginic antibody
activity is associated with a unique immunoglobulin isotype,
which is now called IgE. As expected, identification of IgE
facilitated the analysis of immunologic mechanisms of reaginic
hypersensitivity. Subsequent studies revealed that IgE
specifically bound to basophilic granulocytes and mast cells
through the Fc portion of the molecules and that cross-linking of
the cell-bound IgE antibody molecules by allergen induced the
release of bioactive mediators, such as histamine and
leukotrienes, which initiate allergic reactions. (J Allergy Clin
Immunol 2016;137:1646-50.)
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Discuss this article on the JACI Journal Club blog: www.jaci-
online.blogspot.com.
The reaginic antibodywas discovered by Prausnitz andK€ustner
in 1921. They found that an intracutaneous injection of serum
from an allergic patient into a healthy subject followed by next-
day challenge of the skin site with the allergen to which the serum
donor is sensitive resulted in induction of an erythema-wheal
reaction. Because the antibody specific for the allergen was not
detectable in donor serum at that time, the antibody-like sub-
stance responsible for induction of the erythema-wheal reaction
was called ‘‘reagin.’’
In the 1950s, the physicochemical properties of reagin in
sera of patients with hay fever were studied by usingFrom La Jolla Institute for Allergy & Immunology.
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1646various fractionation methods, such as zone electrophoresis, ion
exchange column chromatography, and ultracentrifugation. The
results clearly showed that the physicochemical properties of
reagin were different from the properties of IgG or IgM. After the
third immunoglobulin, IgA, was isolated and characterized,
Heremans and Vaerman1 reported that the apparently pure IgA
preparations obtained from the sera of patients with hay fever
had the skin-sensitizing activity, and their results were confirmed
by several other investigators. By the end of 1964, most
immunologists and allergists believed that reagin is the IgA
antibody specific for allergen.OUR APPROACHES FOR IDENTIFICATION OF
REAGIN IN VITRO
Because our main interest at that time was the structural basis
of the biologic activities of rabbit IgG antibody molecules to
induce allergic reactions in the guinea pig,2 wewondered whether
the principles obtained in animal experiments could be applied for
elucidation of the mechanisms of ‘‘IgA-dependent’’ reaginic
hypersensitivity in human subjects. Thus we immunized blood
group type O subjects with blood group A substance, isolated
IgA in their sera, and examined the immunologic properties of
the IgA antibodies specific for the blood group substance.
To our great surprise, none of the IgA, IgG, and IgM antibodies
against the blood group substance sensitized human skin for the
Prausnitz-K€ustner (PK) reaction.3 Because I believed that the
biological activities of antibodies are determined by the structures
in the Fc portion of the molecules,2 I could not accept that the
anti-ragweed IgA antibody in the sera of patients with hay fever
had skin-sensitizing activity but the IgA antibody against blood
group substance did not. I wondered whether the reaginic activity
in the IgA fraction of sera of patients with hay fever might be
associated with a very minor component that was present in the
IgA fraction as an impurity.
To test this possibility, the rabbit antibody specific for human
IgAwas added to the IgA fraction of the sera of patients with hay
fever to precipitate all IgA in the fraction, and the supernatant was
tested for the presence of reagin by using the PK reaction. The
results clearly showed that all reaginic activity in the IgA
preparation remained in the supernatant, indicating that the
activity is associated with an impurity that is undetectable by
using the usual immunochemical methods.4 However, this finding
brought up another difficult problem. Because the reaginic
activity (PK titer) of the supernatant was comparable with the
FIG 1. Detection of anti-reagin antibodies by PK reactions. For passive
sensitization, 0.05 mL of 1:100 (bottom) to 1:800 (top) dilutions of a mixture
of the patient’s serum with either antiserum (Abs) or normal rabbit serum
(Cont) were injected (see text).
FIG 2. Distribution of gE antibodies against ragweed antigen in chromato-
graphic fractions of the sera of ragweed-sensitive patients from the DEAE
cellulose column. Stepwise elution was made with 0.005 mol/L (I),
0.025 mol/L (II), 0.035 mol/L (III), 0.05 mol/L (IV), and 0.08 mol/L
(V) phosphate buffers, pH 8.0. S, Original serum. The center well of
the agarose plate was filled with anti-reagin (gE) antiserum, followed by
131I-labeled ragweed antigen E.
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obtained, our results suggested that the concentration of the
carrier protein of the reaginic activity in the original serum was
less than 1 mg/mL.
At that time, the requirements for identification of a new
protein were to isolate the protein and prove that the physico-
chemical properties of the pure protein are different from those of
the known proteins. However, such approaches are impossible for
identification of a minor serum component. Thus I changed our
strategy to prepare rabbit antibodies specific for reagin and to
identify the reagin in vitro by using the rabbit antibodies. For this
purpose, we immunized rabbits repeatedly with the reagin-rich
fraction of the sera of patients with hay fever together with
complete Freund adjuvant and absorbed the antiserum with
normal human IgG, IgA myeloma proteins, and IgD myeloma
proteins to remove all antibodies reacting to the known human
immunoglobulin isotypes.5
The antiserum was added to the serum of a patient with
ragweed sensitivity to test the presence of antibodies specific for
reagin in the absorbed rabbit antiserum. After incubation for
24 hours at 48C, the mixture was centrifuged to remove a trace
amount of the precipitate, and 100 to 800 two-fold dilutions of the
supernatant were injected intracutaneously into the left side of my
back (Fig 1). The right side received the same dilutions of the
mixture of the patient’s serum with normal rabbit serum. The
next day, all of the skin sites were challenged with the purified
ragweed antigen E, which was supplied by Drs Merrill Chase
and T. P. King (Rockefeller Institute for Medical Research). As
shown in Fig 1, no erythema-wheal reaction appeared at the left
injection sites, indicating that the rabbit antiserum contained
the antibody specific for human reagin and that the rabbit
antibody specifically removed reagin in the patient’s serum.5
Since the rabbit antibody specific for reagin became available,
attempts have been made to identify reagin in vitro by using the
rabbit antibody and to determine the physicochemical properties
of reagin. For this purpose, the globulin fraction of sera of
patients with ragweed sensitivity was fractionated by using
DEAE cellulose column chromatography, and distribution of
reagin in the chromatographic fractions was determined by using
the rabbit anti-reagin antibody. In the agarose plate shown in
Fig 2, the peripheral wells were filled with the original patient’sserum and the chromatographic fractions, and the center well
was filled with the anti-reagin antiserum, followed by 131I-labeled
ragweed antigen E. Autoradiography of the plate indicated that
the precipitin band formed by Fraction II contained the highest
anti-ragweed antibody activity. Determination of the anti-
ragweed reaginic activity of each fraction by using the P-K test
also showed that Fraction II had the highest skin-sensitizing
activity.5,6 Because the protein forming the precipitin band did
not belong to any of the known immunoglobulin isotypes but
contained the antibodies specific for antigen E, we tentatively
called this protein gE because I believed that the human
anti-ragweed antibody detected by the rabbit antiserum was
responsible for induction of erythema-wheal reactions.5
In the experiment shown in Fig 3, the reagin-rich fraction of the
sera of patients with ragweed sensitivity was analyzed by using
radioimmunoelectrophoresis. The fraction was placed in the
well of the agarose plate, and after electrophoresis, the trough
was filled with rabbit anti-gE antiserum, followed by radiolabeled
ragweed antigen E. A visible precipitin band was barely seen in
the stained slide, but the autoradiograph of the slide clearly
showed a fast-moving g-globulin band, indicating that the
electrophoretic mobility of gE is in the fast g-globulin region.6
In a similar manner the molecular weight of gE was determined
by using sucrose density gradient ultracentrifugation and gel
filtration. The results showed that the sedimentation coefficient
of gE is 8.0S, and the molecular weight of the protein is
approximately 190,000, indicating that the physiochemical
properties of gE are different from the properties of the known
immunoglobulin isotypes, such as IgG, IgM, IgA, or IgD. It
was also found that gE molecules contained k and l light chains,
which are common for all the other immunoglobulin isotypes.6 In
addition, gE had the antigenic determinant, which was not shared
by any of the immunoglobulins of known isotypes. The unique
antigenic structure of gE together with the presence of antibody
activity associated with gE was sufficient for the conclusion
that gE represents a distinct immunoglobulin isotype.7
The definitive evidence that convinced us of the relationship
between gE and reagin was provided by measurement of the
FIG 3. Radioimmunoelectrophoresis of the reagin-rich fraction of the
serum of a ragweed-sensitive patient with hay fever. After electrophoresis,
the trough was filled with anti-gE, followed by 131I-labeled ragweed antigen
E. Both the stained slide (top) and autoradiograph (bottom) are shown.
TABLE I. Allergen-binding activity of antibodies in patients’
sera*
Serum
Allergen-binding activity
P-K titergG gA gE IGy IG calz
EK 0.40 0 0.23 0.62 0.63 1600
B 0.26 0 0.38 0.66 0.64 3200
Fic§ 0.16 0.082 0.14 0.33 0.38 800
F§ 0.14 0.016 0.097 0.25 0.27 600
A1 0.23 0 0.10 0.34 0.33 800
W 0.61 0.033 0.099 0.79 0.74 600
P 1.8 0 0.07 1.9 1.9 400
I 1.9 0 0 1.9 1.9 0
Adapted from Table II in Ishizaka et al.8
*Numerals in the table indicate micrograms of antigen E bound by immunoglobulins
in 1 mL of serum.
Measured by precipitation of all immunoglobulins with anti-light chain antibodies.
Values of allergen-binding activity of gG, gA, and gE antibodies were summed.
§Untreated patients (all other patients were treated).
FIG 4. Radioimmunodiffusion analysis of gE isolated from the serum of a
ragweed-sensitive patient. The center well was filled with purified gE.
Peripheral wells were filled with the antiserum specific for each immuno-
globulin isotype, followed by 131I-labeled ragweed antigen E. Both the
stained slide (left) and autoradiograph (right) are shown.
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specific for antigen E in the serum of ragweed-sensitive patients
using radioimmunoassays.8 As shown in Table I, the maximal
dilution of the serum, providing positive PK reactions (PK titer),
correlated with the allergen-binding activity of gE antibody but
not with the activity of gG or gA antibodies in serum. The results
indicated that the intensity of the skin-sensitizing activity of the
patient’s serum is decided by the concentration of gE antibodies
specific for the allergen in the serum. On average, the minimal
concentration of gE antibody required for a positive PK reaction
in sera from 6 patients was 0.25 ng/mL.8
On the basis of these findings, we purified gE in sera of
ragweed-sensitive patients with hay fever by combining several
fractionation methods, and a trace amount of IgG and IgA
remaining in the purified gE fraction was removed by using
homemade anti-IgG and anti-IgA immunosorbents. The final
preparation, which produced positive P-K reactions up to a
dilution of 1:80,000, was analyzed by means of radioimmuno-
diffusion (Fig 4). In the Ouchterlony plate the center well was
filled with purified gE, and the peripheral wells were filled with
rabbit antibodies specific for each immunoglobulin isotype,
followed by the radiolabeled ragweed antigen E. As shown in
Fig 4, only anti-gE formed a visible precipitin band, and the
radiolabeled antigen E bound to the precipitin band. None ofthe known immunoglobulins (ie, IgG, IgA, IgD, and IgM) was
detected in the purified gE preparation. Thus we concluded that
reagin is the gE antibody specific for allergen.9
Association of reaginic activity with gE is not restricted to the
ragweed antigen system. Reaginic activity against the other
allergens, such as house dust and ovalbumin, was also associated
with gE.10IDENTIFICATION OF E MYELOMA PROTEINS
Rabbit anti-gE antibodies were also useful for identification of
patientswith Emyeloma.At that time, Johansson andBennich11 in
Sweden isolated atypical myeloma protein (protein ND). After
they submitted their article for publication, they recognized that
the physicochemical properties of the myeloma protein were
almost identical to the properties of gE described in our previous
publication.6 Thus they contacted us, and we exchanged our
rabbit anti-gE and their sheep antiserum specific for the
myeloma protein ND. In the experiment shown in Fig 5, we tested
whether the antibodies specific for themyelomaproteinNDbind to
gE. In the agarose plate the center well was filled with the purified
gE preparation obtained from serum from a ragweed-sensitive
patient with hay fever. Peripheral wells were filled with sheep anti-
serum specific for the myeloma protein and rabbit antibodies spe-
cific for each immunoglobulin isotype, followed by radiolabeled
ragweed antigen E. Autoradiography of the plate clearly showed
that the antibodies specific for the myeloma protein ND and our
anti-gE formed a single precipitin band of identical specificity
with gE, indicating that the myeloma protein ND possesses the
gE-specific antigenic determinants and therefore that the ND pro-
tein is the E myeloma protein.12 Association of antibody activities
with gE, together with the presence of the myeloma protein with
the antigenic determinant specific for gE, were sufficient for the
conclusion that gE represents a unique immunoglobulin isotype.
Thus the World Health Organization (WHO) officially named
this protein IgE in 1968.
Our anti-IgE antibodies were useful for identification of the
second case of E myeloma as well. The patient (patient PS)
visited Dartmouth Medical School Hospital in 1968. Because
the blood test revealed that 65% of his leukocytes were plasma
cells, his disease was diagnosed as plasma cell leukemia, and
his serum was sent to Mount Sinai Hospital, New York, for
identification of the isotype of the myeloma protein. However,
the M protein did not produce a precipitin band with any of the
antiserum specific for IgG, IgA, or IgD. Considering the
possibility that the myeloma protein might belong to IgE
isotype, Dr Kochwa at Mount Sinai Hospital sent the serum
FIG 5. Antigenic identity of gE and myeloma protein ND. Purified gE from
the sera of ragweed-sensitive patients was placed in the center well.
Peripheral wells were filled with the antiserum specific for ND protein
and the antibodies specific for each human immunoglobulin isotype,
followed by 131I-labeled ragweed antigen E.
FIG 6. Identification of IgE on human basophilic granulocytes: autoradio-
graph of normal human leukocytes treated with 125I-labeled anti-IgE.
*CD23 on lymphocytes was not detected in this experiment because 125I-labeled anti-
IgE–treated leukocytes were washed extensively before the smears were made. IgE
bound to CD23 should have dissociated by washing.
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obtained by using block electrophoresis produced a strong
precipitin band with our anti-IgE but not with any of the
antibodies specific for the other isotypes. Examination of
peripheral blood and bone marrow smears of the patient by
means of immunofluorescence revealed that nearly all plasma
cells and some lymphoblasts were IgE-producing cells, and the
M protein in the serum of the patient was identified as l type
E myeloma protein.13
The concentration of E myeloma protein in the plasma of
patient PS was 30 to 40 mg/mL. Because he received plasma-
pheresis once every week for therapeutic purpose, more than 30 L
of his plasma was obtained until his death. Thus we isolated E
myeloma protein from the patient’s plasma using ion-exchange
chromatography followed by gel filtration, prepared the Fc
fragment of the myeloma protein by means of papain digestion,14
and immunized rabbits and a goat with the Fc fragment. Immuno-
diffusion analysis in the Ouchterlony plate showed that the
antiserum against the Fc fragment formed a single precipitin
band of identical specificity with the PS protein, ND protein,
and IgE-rich fraction of the sera of patients with hay fever, but
no visible precipitin band with normal serum, which contained
less than 0.2 mg/mL IgE.
At that time, many allergists and immunologists were inter-
ested in the IgE system, but they could not prepare monospecific
anti-IgE. Thus we have sent purified PS protein and/or the
antiserum specific for the Fc fragment of PS protein to many
investigators in the United States and Europe on request. Looking
to the past, the number of shipments of PS protein/anti-IgE to our
colleagues for the next 10 years was close to 100. We believe that
the PS protein and the anti-Fcε antibodies facilitated the progress
of allergy research in the 1970s.
PS protein was quite useful for preparation of commercial anti-
IgE antiserum as well. Immediately after our report to the WHO
on identification of PS protein as IgE myeloma protein, Dr David
Rowe at theWHO selected 3 companies in the United States and 3
companies in Europe and asked us to send purified PS protein to
these companies for preparation of commercial anti-IgE
antiserum. Because Dartmouth Medical School also supplied
the plasma of patient PS to such companies, most of the
monospecific anti-IgE used in the world for the next 10 years
was prepared by using PS protein.IMMUNOLOGIC MECHANISMS OF IgE-MEDIATED
ALLERGY
When we initiated our studies on reaginic antibodies in 1963,
some allergists told us that reagin is useful for diagnostic purpose
but that the cause of allergic diseases, such as hay fever, is
idiosyncratic and that reagin is not involved in the pathogenesis of
allergic diseases. However, identification of reagin as IgE
antibodies facilitated elucidation of the immunologic mecha-
nisms of allergic reactions and raised the possibility that IgE
antibodies are involved in the pathogenesis of allergic diseases.
In the course of our studies on IgE, we found that an
intracutaneous injection of only 1 to 2 ng/mL anti-IgE to healthy
subjects resulted in induction of the erythema-wheal reaction,
whereas injection of even 1 mg/mL of the antibodies specific for
IgG, IgA, IgM, or IgD did not do so.15 Because healthy subjects
have IgE, mechanisms of the skin reaction were considered to be
the result of binding of anti-IgE antibodies to IgE on some normal
cells in skin tissues. It was also found that human IgE antibodies
sensitize not only human skin but also monkey lung tissue and
mediate the antigen-induced release of histamine and leukotri-
enes from tissue.16 Sensitization of homologous species with
IgE antibodies was observed at the cellular level as well. Since
1964, it has been known that incubation of leukocytes of atopic
patients with allergen resulted in histamine release.17 In this
system we found that antibodies specific for IgE induced
histamine release from the leukocytes of not only patients with
hay fever but also healthy subjects. These results indicated that
some human leukocytes bear IgE molecules on their cell
surfaces.18
Since the second E myeloma protein (PS protein) became
available for our research, anti-IgE antibody was specifically
purified by using the myeloma protein, and the purified anti-IgE
facilitated identification of target cells for IgE. In the experiment
shown in Fig 6, normal human leukocytes were incubated with
125I-labeled anti-IgE in the presence of EDTA, which prevented
histamine release. Autoradiography of leukocytes clearly showed
that radiolabeled anti-IgE bound to basophilic granulocytes but
not to the other leukocytes, such as neutrophils, eosinophils,
monocytes, or lymphocytes.19* The results indicated that
FIG 7. Selective binding of IgE on monkey mast cells. E myeloma protein
PS was injected intracutaneously into a monkey. Twenty-four hours later,
the skin tissues were treated with 125I-labeled anti-IgE, and frozen sections
of the tissues were examined. Both the stained slide (bottom) and
autoradiograph (top) are shown.
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antibody reaction on basophils resulted in release of
histamine from the cells. Cells sensitized with IgE were
identified in tissues as well. In this experiment the E myeloma
protein PS was injected into monkeys, and their tissues were
treated with 125I-labeled anti-IgE. Autoradiography of frozen
tissue sections clearly showed the selective binding of Emyeloma
protein to mast cells in the skin, omentum, small intestine,
and bronchi, indicating that mast cells have receptors for IgE on
their surfaces (Fig 7).20 It was also found that IgE molecules
bind to the receptors through the Fc portion of the molecule14
and that cross-linking of cell-bound IgE antibody molecules by
antigen is responsible for activation of target cells for mediator
release.21,22
Identification of the receptors for IgE on basophils and mast
cells led to subsequent research on FcεRI by Dr Henry Metzger
and his associates, followed by extensive studies by many
investigators on the biochemical pathways for the IgE-mediated
release of chemical mediators and the synthesis of cytokines by
mast cells and basophils.
We are very pleased that the IgE system has been used for
elucidation of the immunologic and biochemical mechanisms of
allergy and for clinical studies on allergic diseases by many
investigators for the past 50 years.REFERENCES
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